|Bid||1.00 x 100000|
|Ask||1.01 x 3000000|
|Day's range||1.00 - 1.05|
|52-week range||0.22 - 1.65|
|PE ratio (TTM)||N/A|
|Forward dividend & yield||N/A (N/A)|
|1y target est||N/A|
The Auscann Group Holdings Ltd (ASX:AC8) share price is one of a number in the pot stock industry being smoked today. Here’s what you need to know…
Shares of Medlab Clinical Ltd (ASX:MDC) have had an excellent start to 2018 with the company's share price rising 37% to $1.07 following last week's announcement that it has received a licence from the Victorian State Government to sell its cannabis based medicine NanaBis and NanaBidial.
Canadian pot stocks have seen astronomical gains recently on the back of California’s legalisation of marijuana for recreational use. The Canadian market is already anticipating strong revenues for their local cannabis companies once Prime Minister Justin Trudeau follows through on his promise to legalise weed by July. So what do these overseas developments mean for Australian pot stocks – and how can you gain exposure to this fledgling multi-billion dollar industry?
The Auscann Group Holdings Ltd (ASX:AC8) share price is one of a number in the pot stock industry smoking the market on Wednesday. Here’s why…